Insigneo Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Insigneo Advisory Services's VRTX Position: Q1 2026 in Review
Insigneo Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 49% in Q1 2026, selling an estimated $293K and leaving 656 shares worth $293K. The position accounts for 0.02% of the portfolio, ranked #511.
Insigneo Advisory Services first reported a position in VRTX in Q2 2023 and has held it in 11 quarters since. The position peaked at $611K in Q3 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Insigneo Advisory Services held 656 shares of Vertex Pharmaceuticals worth $293K as of Q1 2026.
- Insigneo Advisory Services sold 629 Vertex Pharmaceuticals shares in Q1 2026, an estimated $293K.
- Vertex Pharmaceuticals made up 0.02% of Insigneo Advisory Services's portfolio in Q1 2026, its #511 holding.
- Insigneo Advisory Services first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 11 quarters since.
- Insigneo Advisory Services's Vertex Pharmaceuticals position peaked at $611K in Q3 2024.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Insigneo Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.